Announcements

Call For Publication Volume 7 Issue 2, April 2025

2024-11-14

ANNOUNCEMENT

Since Volume 6 Issue 1 Year 2023 to Volume 10 Issue 2 Year 2027, JFM has been indexed and accreditated in the Science and Technology Index (SINTA) 3, by the Ministry Of Education, Culture, Research, And Technology Of The Republic Of Indonesia.

We open the opportunity for Lecturers, Academics, and Practitioners in the field of Pharmacy to publish their writings in the Jurnal Farmasimed (JFM). We will publish the received article after going through the review process in Volume 7 Issue 2, April 2025, for the accepted article we will publish it in the next period.

Get Article Template

IMPORTANT DATE :
November 1 2024 - Maret 30, 2025, Submission, Review and Revision
30 Maret, 2025,
Deadline for Paper Submission
April 1-15, 2025, Copyediting and Proofreading
April 16-30, 2025, Production and Publication

Read more about Call For Publication Volume 7 Issue 2, April 2025

Current Issue

Vol. 7 No. 1 (2024): Jurnal Farmasimed (JFM)
					View Vol. 7 No. 1 (2024): Jurnal Farmasimed (JFM)

Jurnal Farmasimed (JFM) Volume 7 Number 1 Period May 2024 - October 2024. This journal provides space for academics, researchers and users of research and service results to disseminate, inform, discuss and use the results of research and service as an effort to improve the quality of policy in the pharmaceutical sector. scientifically based and accountable. This journal presents research results, community service and scientific articles in the pharmaceutical field. The research and community service articles published in this journal are important topics in the development of science in the pharmaceutical field, helping to solve problems related to pharmaceuticals and helping to improve the quality of human life. The Jurnal Farmasimed (JFM) is independent, scientific, providing equal opportunities to academics from various levels and origins of higher education.

Download CoverDownload Table of Content

Published: 2024-10-31

Articles

View All Issues